Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
NCT ID: NCT05024955
Last Updated: 2024-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2021-07-20
2024-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community
NCT02914899
DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement
NCT03891602
Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening
NCT04498052
Shared Decision Making in Patients With Lung Cancer
NCT05191485
Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening
NCT03077230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Understand how Chinese populations in the Unites States who currently smoke or who have partners who smoke perceive the process of shared health-related decision-making and their preferences in terms of role involvement, and the barriers to and facilitators of shared decision-making.
II. Evaluate current publicly available lung cancer screening tools from the perspective of Chinese adults who smoke or who have partners who smoke.
OUTLINE:
Participants attend an interview over 45-60 minutes and/or a focus group over 1.5 to 2 hours.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (interview, discussion)
Participants attend an interview over 45-60 minutes and/or a focus group over 1.5 to 2 hours.
Discussion
Attend a focus group
Interview
Attend interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Discussion
Attend a focus group
Interview
Attend interview
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Live in the U.S. (either citizens or have lived in the U.S. for at least 5 years or more, i.e. long-term residents)
* Age 50-80
* Currently smokes or partner of a person who smokes
* Speak English and/or Mandarin
50 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert J Volk
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-08583
Identifier Type: REGISTRY
Identifier Source: secondary_id
2021-0101
Identifier Type: OTHER
Identifier Source: secondary_id
2021-0101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.